ENTITY

HLB Therapeutics (115450 KS)

Analysis

Health Care • South Korea

HLB Therapeutics Co.,Ltd. operates pharmaceutical development businesses. The Company develops gene medicines, cell medicines, and other medical products. HLB Therapeutics conducts businesses in South Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00